Your browser doesn't support javascript.
loading
Oncologic outcomes after nipple-sparing mastectomy: A single-institution experience.
Frey, Jordan D; Alperovich, Michael; Kim, Jennifer Chun; Axelrod, Deborah M; Shapiro, Richard L; Choi, Mihye; Schnabel, Freya R; Karp, Nolan S; Guth, Amber A.
Affiliation
  • Frey JD; Department of Plastic Surgery, NYU Langone Medical Center, New York, New York.
  • Alperovich M; Department of Plastic Surgery, NYU Langone Medical Center, New York, New York.
  • Kim JC; Department of Surgery, NYU Langone Medical Center, New York, New York.
  • Axelrod DM; Department of Surgery, NYU Langone Medical Center, New York, New York.
  • Shapiro RL; Department of Surgery, NYU Langone Medical Center, New York, New York.
  • Choi M; Department of Plastic Surgery, NYU Langone Medical Center, New York, New York.
  • Schnabel FR; Department of Surgery, NYU Langone Medical Center, New York, New York.
  • Karp NS; Department of Plastic Surgery, NYU Langone Medical Center, New York, New York.
  • Guth AA; Department of Surgery, NYU Langone Medical Center, New York, New York.
J Surg Oncol ; 113(1): 8-11, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26628318
ABSTRACT

INTRODUCTION:

Long-term oncologic outcomes in nipple-sparing mastectomy (NSM) continue to be defined. Rates of locoregional recurrence for skin-sparing mastectomy (SSM) and NSM in the literature range from 0% to 14.3%. We investigated the outcomes of NSM at our institution.

METHODS:

Patients undergoing NSM at our institution from 2006 to 2014 were identified and outcomes were analyzed.

RESULTS:

From 2006 to 2014, 319 patients (555 breasts) underwent NSM. One-hundered and fourty-one patients (237 breasts) had long-term follow-up available. Average patient age and BMI were 47.78 and 24.63. Eighty-four percent of patients underwent mastectomy primarily for a therapeutic indication. Average tumor size was 1.50 cm with the most common histologic type being invasive ductal carcinoma (62.7%) followed by DCIS (23.7%). Average patient follow-up was 30.73 months. There was one (0.8%) incidence of ipsilateral chest-wall recurrence. There were 0.37 complications per patient.

CONCLUSIONS:

We examined our institutional outcomes with NSM and found a locoregional recurrence rate of 0.8% with no nipple-areolar complex recurrence. This rate is lower than published rates for both NSM and SSM.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Mastectomy / Nipples Limits: Adult / Female / Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: J Surg Oncol Year: 2016 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Mastectomy / Nipples Limits: Adult / Female / Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: J Surg Oncol Year: 2016 Type: Article